Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$435M |
| 2 |
Amazon
AMZN
|
+$334M |
| 3 |
Moderna
MRNA
|
+$53.9M |
| 4 |
Linde
LIN
|
+$44.2M |
| 5 |
DTE Energy
DTE
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$63.6M |
| 2 |
Comcast
CMCSA
|
+$39.7M |
| 3 |
Evergy
EVRG
|
+$38.5M |
| 4 |
Public Service Enterprise Group
PEG
|
+$38.4M |
| 5 |
Bio-Techne
TECH
|
+$30.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.37% |
| 2 | Consumer Discretionary | 10.36% |
| 3 | Financials | 7.14% |
| 4 | Industrials | 6.8% |
| 5 | Healthcare | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
NewMarket
NEU
$8.62B
| – | – |
-2,102
| Closed | -$799K |
|
2652
Vitamin Cottage Natural Grocers
NGVC
$637M
| – | – |
-19,910
| Closed | -$349K |
|
2653
Nice
NICE
$5.87B
| – | – |
-1,464
| Closed | -$319K |
|
2654
Nelnet
NNI
$4.55B
| – | – |
-4,464
| Closed | -$325K |
|
2655
Northern Oil and Gas
NOG
$2.91B
| – | – |
-191,214
| Closed | -$2.31M |
|
2656
Enpro
NPO
$6.62B
| – | – |
-10,994
| Closed | -$937K |
|
2657
National Presto Industries
NPK
$1.07B
| – | – |
-2,175
| Closed | -$222K |
|
2658
Nerdy
NRDY
$89.8M
| – | – |
-5,474
| Closed | -$814K |
|
2659
NETGEAR
NTGR
$571M
| – | – |
-28,453
| Closed | -$1.17M |
|
2660
Nutanix
NTNX
$18.3B
| – | – |
-61,390
| Closed | -$1.63M |
|
2661
Nuvation Bio
NUVB
$2.43B
| – | – |
-159,162
| Closed | -$1.66M |
|
2662
NVIDIA
NVDA
$5.2T
| – | – |
-331,840
| Closed | -$4.43M |
|
2663
Navigator Holdings
NVGS
$1.36B
| – | – |
-40,188
| Closed | -$358K |
|
|
NVO
2664
Novo Nordisk
NVO
$207B
| – | – |
-37,786
| Closed | -$1.27M |
|
2665
NVR
NVR
$16.9B
| – | – |
-375
| Closed | -$1.77M |
|
2666
Northwest Bancshares
NWBI
$2.26B
| – | – |
-100,835
| Closed | -$1.46M |
|
2667
Northwest Natural Holdings
NWN
$2.08B
| – | – |
-50,093
| Closed | -$2.7M |
|
2668
News Corp Class B
NWS
$18.7B
| – | – |
-13,155
| Closed | -$309K |
|
2669
Blue Owl Capital
OBDC
$5.57B
| – | – |
-63,183
| Closed | -$870K |
|
2670
Omega Healthcare
OHI
$14.1B
| – | – |
-77,333
| Closed | -$2.83M |
|
2671
Oil States International
OIS
$522M
| – | – |
-72,988
| Closed | -$440K |
|
2672
Oneok
OKE
$58.8B
| – | – |
-5,196
| Closed | -$263K |
|
2673
Omnicom Group
OMC
$24B
| – | – |
-61,700
| Closed | -$4.58M |
|
2674
OP Bancorp
OPBK
$228M
| – | – |
-19,072
| Closed | -$201K |
|
2675
Option Care Health
OPCH
$3.55B
| – | – |
-86,904
| Closed | -$1.54M |
|
Similar funds
Michael Gelband's Q2 2021 Portfolio in Review
As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.
- Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
- Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
- Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
- Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
- Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
- Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
- Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.